Stock PGMN3 EMPREENDIMENTOS PAGUE MENOS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Empreendimentos Pague Menos S.A.

Equities

PGMN3

BRPGMNACNOR8

Market Closed - Sao Paulo
Other stock markets
 04:06:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.48 BRL +0.40% Intraday chart for Empreendimentos Pague Menos S.A. -1.20% -37.37%
Mar. 05 Transcript : Empreendimentos Pague Menos S.A., Q4 2023 Earnings Call, Mar 05, 2024
Mar. 04 Empreendimentos Pague Menos S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.23 for the 2024 fiscal year.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • Low profitability weakens the company.
  • The company benefits from high valuations in earnings multiples.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
EMPREENDIMENTOS PAGUE MENOS S.A. Stock Empreendimentos Pague Menos S.A.
-37.37% 278M -
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.59% 15.18B
B-
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.1B
B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+9.54% 6.12B
C
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.97B
C+
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 5.65B
B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
D-
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+51.58% 4.26B -
C
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.22% 3.58B
B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-16.75% 3.26B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. PGMN3 Stock
  4. Ratings Empreendimentos Pague Menos S.A.